Pharmaceutical drug development services; Pharmaceutical drug development services via software using artificial intelligence; Pharmaceutical drug development services via software using machine learning; Preclinical drug discovery and development services used for identifying, designing and/or optimizing chemical compounds; Preclinical drug discovery and development services used for identifying, designing and/or optimizing chemical compounds via software using artificial intelligence; Preclinical drug discovery and development services used for identifying, designing and/or optimizing chemical compounds via software using machine learning; Pharmaceutical evaluation and preclinical evaluation of chemical series or lead compounds in drug discovery; Pharmaceutical evaluation and preclinical evaluation of chemical series or lead compounds in drug discovery via software using artificial intelligence; Pharmaceutical evaluation and preclinical evaluation of chemical series or lead compounds in drug discovery via software using machine learning; Pharmaceutical drug development and discovery services, namely, identifying, designing, optimizing, and developing chemical lead series or lead compounds via software using artificial intelligence, machine learning, computational modeling, DNA-encoded library screening platform, high-throughput screening, medicinal chemistry, ADME, biology, pharmacology and/or non-GLP safety testing